Institute for International Research

Dear Colleague,

What Are the Top Ten Challenges Cited By Scientists in Vaccines Development?

• Improving Compliance Through Better Understanding of Regulatory Requirements
• Formulating More Thermostable Vaccines
• Defining and Implementing a Development Plan Leading To a Commercially Viable Cancer Vaccine
• Utilizing Forced Degradation and Accelerated Study Practices When Developing Vaccines
• Improving Stability and Robustness When Developing Influenza Vaccines
• Taping Into Methods to Advance Vaccine Stability Testing to Minimize Development Changes
• Using Aluminum-Containing Adjuvants Effectively For Improved Formulation and Stability
• Identifing and Solving Potential Adjuvant-Antigen Formulation Issues
• Addressing the regulatory issues arising from incorporating a new adjuvant in your vaccine
• Using Innovative Vaccine Delivery Techniques and Predict Their Impact on Formulation and Stability Studies

The vaccines industry, ranging from large pharma to small biotech, to government and academic researchers, has cited the above ten challenges as the most time-consuming aspects of vaccine development.We’ve gathered the industry leaders who are 100% focused on best practices to address the above challenges. The speaking faculty provides solutions and strategies through case studies, best practices, and interactive discussions in vaccine development with lessons that you can implement at your company.

Case Studies Delivering Solutions to Your Most Pressing Formulation & Stability Challenges

The Gates Foundation will address the state of the industry on the Impact of Vaccine Development in Addressing the Grand Challenges of Global Health. Merck Vaccines R&D provides a case study on the formulation & forced degradation practices during the development Gardasil. Novartis Vaccines R&D shares how they develop stability-indicating assays for accurate testing. The PATH Initiative and reveals strategies to reformulate vaccines for greater thermostability in developing countries.

New Technologies and Next Wave Vaccines For Greater Innovation

Vical reveals the key strategies they take in developing DNA Vaccine Candidates. ODC Therapy explores approaches to overcome the hurdles in personalized, therapeutic vaccines. Purdue University, Iomai, and Vaxine look ahead with new adjuvant developments and how they will affect your vaccine formulations. Tulane University and University of London School of Pharmacy share innovative vaccine delivery techniques and their impact on formulation and stability.

This is your chance to enhance your knowledge of the science behind vaccine development with X case studies, and to engage in open dialogue with fellow vaccine developers through interactive breakout sessions, panel discussions, and networking time. IIR welcomes you to The Vaccines Development Forum. Come and take advantage of this outstanding opportunity to hear and learn from the experts and develop relationships with other professionals in your field.We look forward to greeting you in Las Vegas!

Sincerely,

Tricia Carle
Event Director
IIR